Cargando…

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma

BACKGROUND: CXC chemokine receptor gene family consists of seven well-established members which are broadly involved in biological functions of various cancers. Currently, limited studies have shed light on the expression profile of CXCR family members (CXCRs), as well as their prognostic value, in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Yiming, Zhou, Chongchang, Cao, Yujie, Li, Qun, Deng, Hongxia, Gu, Shanshan, Wu, Yidong, Shen, Zhisen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382762/ https://www.ncbi.nlm.nih.gov/pubmed/35978426 http://dx.doi.org/10.1186/s12957-022-02713-z

Ejemplares similares

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
por: Deng, Hongxia, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
por: Deng, Hongxia, et al.
Publicado: (2023)

ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhou, Chongchang, et al.
Publicado: (2023)

Neddylation inhibitor MLN4924 sensitizes head and neck squamous carcinoma cells to (S)-10-hydroxycamptothecin
por: Gu, Shanshan, et al.
Publicado: (2023)

tRNA(Ini) (CAT) inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells
por: Li, Jun, et al.
Publicado: (2021)

Spatial metabolomics in head and neck tumors: a review
por: Zheng, Ye, et al.
Publicado: (2023)

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2019)

Long non-coding RNA AC023794.4-201 exerts a tumor-suppressive function in laryngeal squamous cell cancer and may serve as a potential prognostic biomarker
por: Shen, Zhisen, et al.
Publicado: (2020)

The expression profile and clinical application value of hsa_circ_0016148 in head and neck squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2021)

SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer
por: Li, Jinyun, et al.
Publicado: (2020)

Construction of a Ferroptosis-Related Gene Signature for Head and Neck Squamous Cell Carcinoma Prognosis Prediction
por: Li, Qun, et al.
Publicado: (2021)

The Role and Mechanism of MALAT1 Long Non-Coding RNA in the Diagnosis and Treatment of Head and Neck Squamous Cell Carcinoma
por: Ye, Dong, et al.
Publicado: (2021)

Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis
por: Shen, Zhisen, et al.
Publicado: (2018)

Expression of the long noncoding RNA RP11‐169D4.1‐001 in Hypopharyngeal Squamous cell carcinoma tissue and its clinical significance
por: Shen, Zhisen, et al.
Publicado: (2019)

Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
por: Hu, Lian-Tao, et al.
Publicado: (2022)

The Expression Profile, Clinical Application and Potential Tumor Suppressing Mechanism of hsa_circ_0001675 in Head and Neck Carcinoma
por: Cao, Yujie, et al.
Publicado: (2022)

SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males
por: Shen, Zhisen, et al.
Publicado: (2016)

The Prognostic Value of the DNA Repair Gene Signature in Head and Neck Squamous Cell Carcinoma
por: Ming, Ruijie, et al.
Publicado: (2021)

Identification of cuproptosis‐related subtypes and characterization of the tumor microenvironment landscape in head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Prognostic Value and Therapeutic Perspectives of CXCR Members in the Glioma Microenvironment
por: He, Jiarong, et al.
Publicado: (2022)

The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members
por: Guo, Kaibo, et al.
Publicado: (2019)

The expression profiles and prognostic values of HSPs family members in Head and neck cancer
por: Fan, Guorun, et al.
Publicado: (2020)

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma
por: Bossi, Paolo, et al.
Publicado: (2016)

Prognostic Value of Eight-Gene Signature in Head and Neck Squamous Carcinoma
por: Liu, Baoling, et al.
Publicado: (2021)

Identification of a cuproptosis-related lncRNA signature to predict the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_641ij8g2d0er71prkvfm9ec6i9